The OSR, Office of Clinical Trial Activation (OCTA), and Contracts and Grants Accounting (CGA) are working to ensure continuity of services for researchers, as well as prioritizing COVID-19 research and clinical trials.
Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources.
Please visit the Office of Research COVID-Related Research website to find a searchable list of all COVID related funding opportunities
Please notify your RSC of any intention to submit a proposal ASAP.
Below is a list of NIH funding opportunities only. The charts below are separated by:
These funding opportunities are also part of the searchable list on the Office of Research COVID website.
NIH - National Institutes of Health
Go to the NIH COVID-19 Information for NIH Applicants and Recipients page for a complete list of Funding Opportunities Specific to COVID-19
OD - NOT-OD-20-162 Request for Information (RFI): Inviting Comments and Suggestions on University-Based Approaches for COVID-19 Surveillance Testing to Review the Current Landscape Response Due Date: August 26, 2020
OD - NOT-OD-20-118 Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency
Related NOSIs: NOT-AT-20-011, NOT-MD-20-019, NOT-AG-20-022, NOT-ES-20-020, NOT-AA-20-011, NOT-HG-20-030, NOT-GM-20-025, NOT-MH-20-047,NOT-OD-20-097, NOT-DA-20-047, NOT-LM-20-010, NOT-OD-20-107
NCI - NOT-CA-20-082 NOSI: NCI Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) Rolling Submission from July 2, 2920 through August 14, 2020
NCI - NOT-CA-20-065 Request For Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences, Response Due: May 26, 2020
NCI - NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be redirected to COVID-19-Related Research During the Crisis
NHLBI - Research Opportunity Announcement (ROA) OTA-20-011 ACTIV Integration of Host-targeting Therapies for COVID19 Stage 1 Letters of Request Due: Friday, May 15, 5 PM EDT. Additional letters of request considered on a monthly basis June 15, July 15, and August 15.
NIBIB - NIH POCTRN - Fast-Track Program for COVID-19 Test Development and Distribution Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing Rolling Submission from April 29, 2020 until further ntoice.
COVID-19 Applications:
| NIH IC | NOSI | NOSI Expiration | Title | FOAs Used |
|
NIDCR |
|
|||
|
NIMHD/ NIAAA/ NIDA/ODP/ OBSSR/ ORWH |
|
|||
|
NICHD |
NOT-HD-20-031 | 05/08/23 | Research on Rehabilitation Needs Associated with the COVID-19 Pandemic |
|
|
CDC/NIOSH |
|
|||
|
NHLBI |
NOT-HL-20-814 | 07/06/24 | The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) |
|
|
NIDDK |
|
|||
|
NICHD/NIAID |
|
|||
|
NINDS/NEI/ NHLBI/NIA/ NIAAA/NICHD/ NIDCD/NIDA/ NIGMS/NIMH/ NIMHD/NCI |
NOT-NS-20-005 | 12/08/22 |
NOSI: Research in the Emergency Setting |
|
|
NCI/ODP |
|
|||
|
NICHD/ORWH |
NOT-HD-20-021 | 07/16/23 | Emerging Viral Infections and Their Impact on the Male and Female Reporductive Tract |
|
|
NICHD |
|
|||
|
NIAID |
NOT-AI-20-065 | 09/01/21 | Availability of Emergency Awards for limited Clinical Trials to Evaluate Therapeutic and vaccine Candidates Against SARS-CoV-2 |
|
|
NIMHD |
NOT-MD-20-026 | 05/08/21 | Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations |
|
|
NIMHD/NIAMS/ NIDA/NIMH/ NLM/NCI/ODP/ OBSSR |
NOT-MD-20-030 corrects submission information |
05/08/23 | Simulation Modeling and Systems Science to Address Health Disparities |
|
|
NCI |
|
|||
|
OD/NHLBI/ NIAID/NIAMS/ NICHD/NIDA/ NIMHD/FIC |
|
|||
|
OD/NIA/ NICHD/ NIDCD/ NIDCR/ NINDS/ NINR/NLM |
|
|||
|
OD/NHLBI/ NIAAA/NIAMS/ NIBIB/NICHD/ NIDCR/NIMHD/ NLM/NCATS |
|
|||
| OD/NHLBI/
NIAAA/NIAMS/ NIBIB/NICHD/ NIDCR/NIMHD/ NLM/NCATS |
|
|||
|
OD/NIMHD/NIA NHLBI/NICHD/ NIDCD/NIDCR/NIDA/ NIEHS/NIGMS/NIMH/ NINR/NLM/NCCIH/ NCATS/NCI/NIAID/ NIDDK/NIAAA |
|
|||
|
OD/NHLBI/ NHGRI/NIA/NIDCR/ NIDA/NCATS/NCI/ Common Fund |
|
|||
| OD/NHLBI/
NIAAA/NIAMS/ NIBIB/NICHD/ NIDCR/NIMHD/ NLM/NCATS |
|
|||
|
OD/NIAAA/NIDCR/ NIDDK/NIDA/NIGMS/ NINR/NIMHD/NLM |
|
|||
|
OD/NIDA/NIEHS/ NIGMS/NLM |
|
|||
|
OD/NIA/NIAAA/NICHD/ NCCIH/NCI/NHLBI |
|
|||
|
OD/NIMHD/NIA NEI/NHLBI/NHGRI/ NIAMS/NIBIB/NICHD/ NIDCD/NIDCR/NIDA/ NIEHS/NIGMS/NIMH/ NINR/NLM/FIC/NCCIH/ NCATS/NCI/NIAID/ NIDDK/NIAAA/NINDS |
|
|||
|
NIMHD/NEI/NIA/ NIAAA/NICHD/NIDCD/ NIDCR/NIDDK/NIDA/ NIEHS/NIMH/NINR/ NCCIH/NCATS/ODP/ ORWH/SGMRO |
|
|||
|
NHGRI/NICHD/ NIMH/NINDS |
|
|||
| NIA |
|
|||
| NIAAA |
|
|||
| NIAID |
|
|||
| NIH Office of Strategic Coordination |
|
|||
| NICHD |
|
|||
| NIAID |
Early Termination |
9/8/21 9/8/20 |
Select Research Areas for Severe Acute-Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
|
| OPPNET, NIA, NIAAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH, OBSSR | NOT-OD-20-103 | 3/18/21 | Notice of Additional Due Date and Additional "Areas of Focus Especially of Interest" of PAR-19-373 and PAR-19-384 |
|
| NIDA | 1/8/24 |
Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders |
|
|
| NIDCD | 9/8/20 |
NIDCDE is Interested in Supporting Research on the Impact of COVID-19 on Mission specific Sensory and Communication Disorders This NOSI applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022 |
|
|
| NIDCR | Infrastructure Access for Research on Coronavirus disease 2019 (COVID-19) Conducted in the National Dental Practice-based Research Network |
|
||
| NIDDK |
|
|||
| NCATS | NOT-TR-20-012 | 10/17/20 | Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) |
|
| NIEHS |
NOT-ES-20-015 Rescinded 4/10/20 replaced by NOT-ES-20-20 |
4/9/20 | NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) |
|
COVID-19 Supplements for Exisiting Awards:
|
NIH IC |
COVID NOSI |
Competitive PA-20-135 expands scope |
Competitive expands scope |
Adminis. within scope |
Noted Requirements (please see NOSI for all requirements specified) |
Deadline | Release | Expires |
|
OD/NLM |
NOT-OS-20-159 | X |
Also see: |
8/21/20 | 8/6/20 | 8/22/20 | ||
|
OD/NIA/ NICHD/ NIDCD/ NIDCR/ NINDS/ NINR/ |
NOT-OD-20-152 | X |
Also see: |
9/15/20 | 8/6/20 | 9/16/20 | ||
|
OD/ NIMHD/ NIA/ NEI/ NHLBI/ NHGRI/ NIAAA/ NIAID/ NIAMS/ NIBIB/ NICHD/ NIDCR/ NIDCD/ NIDDK/ NIDA/ NIEHS/ NIGMS/ NIMH/ NINDS/ NINR/ NLM/ FIC/ NCCIH/ NCATS/NCI |
NOT-OD-20-119 | X |
Researchers applying to this NOSI are encouraged to read NOT-OD-20-121, NOT-OD-20-120, RFA-OD-20-013 Applicants are strongly encouraged to contact SEBI program officials prior to developing an application to determine programmatic responsiveness to the NOSI NIH expects that all supplements funded under this NOSI and the related NOSIs will actively coordinate and share data (where allowed) with other grantees, the CDCC, and other research supported by the RADx-UP program |
8/7/20 OR 9/8/20 | 6/12/20 | 9/9/20 | ||
|
OD/ NIMHD/ NIA/ NEI/ NHLBI/ NHGRI/ NIAAA/ NIAID/ NIAMS/ NICHD/ NIDCR/ NIDDK/ NIDA/ NIEHS/ NIGMS/ NIMH/ NINDS/ NINR/ NLM/FIC/ NCCIH/ NCATS/ NCI |
NOT-OD-20-120 | X |
Projects awarded under this NOSI will be expected to work collaboratively with the CDCC (RFA-OS-20-013) and the SEBI projects (NOT-OD-20-119) related to COVID-19 Researchers applying to this NOSI are encouraged to read NOT-OD-20-121, NOT-OD-20-119, RFA-OD-20-013 NIH expects that all competing revisions funded under this NOSI will actively coordinate, collaborate, and share date with other testing research projects, the CDCC, and other research supported by SEBI program as allowed and with considerations under tribal IRB processes |
8/7/20 OR 9/8/20 | 6/12/20 | 9/9/20 | ||
| NIAID | X |
Specific areas of support limited to active BSL3 facilities, generation of critical reagents, expansion of relevant data systems, expansion of CT infrastructure. See Notice for details |
Rolling basis from 7/2/20 to 7/2/21 | 7/6/20 | 7/2/21 | |||
| NIAID |
NOT-AI-20-034 Rescinded 7/6/20 Replaced by NOT-AI-20-059 |
X | FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 | Rolling basis from 3/25/20-3/25/21 | 3/25/20 | 3/25/21 | ||
| NIAID |
NOT-AI-20-031 Rescinded 5/19/20 Replaced by NOSI NOT-AI-20-051 R03, R41/R42, R43/R44 or use PAR-177 PAR-178 See Application Grid above |
X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 4/5/20-4/5/21 | 3/27/20 |
4/5/21 5/19/20 |
||
| NIBIB | NOT-EB-20-008 | X | X |
Limited to DP1, DP2, P41, R00, R01, R03, R15, R21, R24, R37, R41, R43, R44, R56, U01, U18, U24, U2C, U54, UG3, UH2, UH3 Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 4/2/20-11/10/20 | 4/10/20 | 11/10/20 | |
| NCATS | NOT-TR-20-017 | X |
Only existing UG3/UH3, R43/R44, R41/R42, R01, U01 NCATS/NIH Microphysiological Systems FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 5/15/20-1/25/22 | 4/9/20 | 1/26/22 | ||
| NCATS | NOT-TR-20-028 | X | X |
Soliciting current CTSA UL1 & U24 recipients of RFA-TR-17-006 RFA-TR-15-004 PAR-18-940 UL1 component only PAR-18-464 UL1 component only PAR-15-304 UL1 component only RFA-TR-14-009 UL1 Component only Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 5/4/20-11/11/20 | 4/23/20 | 11/11/20 | |
| NCATS | NOT-TR-20-029 | X |
Soliciting current CTSA UL1 & U24 recipients of RFA-TR-17-006 RFA-TR-15-002 RFA-15-TR-004 PAR-18-940 UL1 component only PAR-18-464 UL1 component only PAR-15-304 UL1 component only RFA-TR-14-009 UL1 Component only Admin. Supp. Cannot use streamline submission in eRA. Awarded using appropriations provided by the H.R.748 (PL 116-136) CARES Act issued in unique subaccounts in the PMS and will require separate financial reporting |
Rolling basis 6/15/20 - 11/10/20 | 6/15/20 | 11/11/20 | ||
| NIAAA |
See Data Sharing Expectations |
X | X |
Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis 5/15/20-4/16/21 | 4/16/20 | 4/16/21 | |
|
NIA/ NIMH |
See Data Sharing Expectations |
X | X |
Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 4/6/20-5/1/21 | 4/2/20 | 5/21/21 | |
|
NCCIH/ ORWH |
NOT-AT-20-012 | X | X |
Only existing awardees of NCCIH active awards. Admin. Supp. Cannot use streamline submission in eRA. PA-18-591 and PA-18-935 were reissued with FORMS-F on 5/25/20 Applications started using FORMS-E must be completed by 6/25/20 |
Rolling through 8/17/20 | 5/26/20 | 8/18/20 | |
|
NCCIH/ NIA/ NIAAA |
See Data Sharing Expectations |
X | X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20 |
Rolling basis from 4/10/20-10/6/20 | 4/10/20 | 10/7/20 | |
| NIDA |
See Data Sharing Expectations |
x | x |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will be accepted through 6/25/20 |
Rolling basis from 3/19/20-3/31//21 | 3/19/20 | 3/31/21 | |
| NIDCR | X | X |
Includes R42, R44, SB1, K01, K08, K23, K25, K99/R00, R01, R15, R37, U01, U19, UH3 Admin. Supplement cannot use streamline submission in eRA Commons Must use application form package with the Competition ID that contains FORMS-F-ADMINSUPP |
6120 and 11/2/20 | 5/5/20 | |||
| NIGMS |
See Data Sharing Expectations |
X |
FOA will be reissued with FORMS-F on May 25. FORMS-E FOA will expire June 25 |
Rolling basis from 3/25-2/5/21 | 3/25/20 | 2/6/21 | ||
| NHLBI | X |
Phase I-III CT, parent P01, R01, R33, R41, R42, R43, R44, U01, U24, U54, UH3, UM1 OA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 5/1/20-10/5/20 | 4/27/20 | 10/6/20 | |||
| NHLBI |
Expires 5/15/20 see NOT-HL-20-782 or OTA-20-011 |
X | X |
Admin. Supp. Cannot use streamline submission in eRA. FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 Contact with NHLBI progran staff well in advance is strongly recommended. |
Rolling basis from 3/17-05/15/20 | 3/17/20 | 5/15/20 | |
|
NLM |
See Data Sharing Expectations |
X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
6/1/20 | 4/16/20 | 6/2/20 | ||
|
NIMHD/ NEI/ NHLBI/ NIA/ NIAAA/ NICHD/ NIDCD/ NIDCR/ NIDDK NIDA/ NIEHS/ NIMH/ NCCIH/ NCATS/ SGMRO |
CHANGES: NOT-MD-21-002 annunces NIMHD withdrawal 10/01/20 NOT-HL-20-802 announces NHLBI withdrawal 8/2/20 |
X | X |
Admin Supplement must use form package with Competition ID FORMS-F-ADMINSUPP Admin. Supplement cannot use streamline submission in eRA Commons Competitive Revision must use form package with Competition ID FORMS-F-COMP-REV |
Rolling basis from 6/10/20 through 12/15/20 | 6/5/20 | 12/20/20 | |
|
NIMHD NIA/ NIMH |
See Data Sharing Expectations NIMHD withdraws 10/01/20 |
X | X |
FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 |
Rolling basis from 5/1/20-5/1/21 | 4/9/20 | 5/1/21 | |
|
NIMH/ NEI/ NHLBI/ NIA/ NIAAA/ NICHD NIDCD/ NIDCR/ NIDDK/ NIDA/ NINR/ NIMHD/ NCCIH/ NCATS/ SGMRO |
NIMHD withdraws effective 10/19/20 |
|
X | X |
Admin Supplement must use form package with Competition ID FORMS-F-ADMINSUPP Admin. Supplement cannot use streamline submission in eRA Commons Competitive Revision must use form package with Competition ID FORMS-F-COMP-REV
|
Rolling basis from 6/10/20 through 12/15/20 | 6/5/20 | 12/30/20 |
|
NIMH NIA/ NIAAA/ NIMHD/ ODP |
See Data Sharing Expectations NOT-MD-21-005 NIMHD withdrawals 10/19/20 |
X | X |
May be co-funded by ODP FOA will be reissued with FORMS-F on May 25. FORMS-E FOA expires June 25 Applications intended for NIMHD received 1019/20 or later will be withdrawan |
Rolling basis from 3/27/20-4/15/21 | 4/9/20 | 4/16/21 | |
|
NINDS |
NOT-NS-20-074 adds RF1 to eligible mechanisms |
X | X |
Limited to P01, P50, RF1,R00, R01, R03, R15, R33, R35, R41, R42, R43, R44, R61, U01, U19, U24, U44, U54, UG3, UH3 Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
Rolling basis from 4/15/20-4/14/21 | 4/30/20 | 4/15/21 | |
|
OD Office of the Director
|
See Data Sharing Expectations |
X |
EsixtingECHO Cohorts, Coordinating Center, Data Analysis Center and PRO Core Awardees Existing Subawardees not eligible Use application form package with Competition ID that contains FORMS-F-ADMINSUPP |
6/22/20 | 5/27/20 | 6/23/20 | ||
|
OBSSR/ NHLBI/ NIA/ NIAAA/ NIDDK/ NIEHS/ NCCIH/ NCI |
See Data Sharing Expectations |
X | X |
Admin. Supplement cannot use streamline submission in eRA Commons FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
Rolling basis from 4/13/20-3/31/21 | 4/13/20 | 4/1/21 | |
|
NCATS |
NOT-TR-20-011 | X |
Supplements U01-PAR-19-099 R21-PAR-19-100 UL1-PAR-19-337 Admin. Supp. cannot use streamline submission in eRA Commons. FOA will be reissued with FORMS-F on May 25. FORMS-E expires June 25 |
5/4/20 AND 11/2/20 | 3/24/20 | 7/10/21 |
Go to our COVID-19 page for sponsor specific guidance, the impact of research and additional resources.